Comprehensive Diagnostic & Therapeutic Reference Profile
Also known as: HL, Hodgkin's Disease, Hodgkin's Lymphoma
Hodgkin Lymphoma (HL) is a B-cell malignancy originating in the lymphatic system. It is characterized by the presence of Reed-Sternberg cells, which are multinucleated giant cells. It is one of the most curable forms of cancer, typically presenting as painless lymphadenopathy.
HL is linked to immune system dysregulation, specifically following infection with the Epstein-Barr virus (EBV). Genetic susceptibility and chronic inflammation play contributing roles, though the exact initiating event remains multifactorial.
The disease arises from germinal center B-cells that have escaped programmed cell death. These cells transform into Reed-Sternberg cells, which secrete cytokines that attract inflammatory cells, forming the bulky tumor microenvironment characteristic of HL.
HL exhibits a bimodal age distribution, with peaks in young adulthood (ages 15–35) and later life (age >55). It occurs slightly more frequently in males.
A. Early Symptoms
A. Clinical Assessment: History and physical exam focusing on nodal distribution.
B. Laboratory Testing: CBC, ESR, LDH.
C. Imaging Studies: PET-CT scan for staging.
D. Functional Tests: Pulmonary function tests (pre-chemotherapy).
E. Biopsy Findings: Excisional lymph node biopsy showing Reed-Sternberg cells.
F. Genetic Testing: FISH analysis for specific translocations.
G. Differential Diagnosis: Non-Hodgkin Lymphoma, reactive lymphadenitis, tuberculosis.
Complete Blood Count (CBC)
Type: Blood Test
Purpose: Assess hematologic status
Expected Findings: Anemia, lymphopenia, or neutrophilia
Interpretation: Systemic inflammatory response and bone marrow involvement
A. Lifestyle Modifications: Smoking cessation, nutritional support.
B. Preventive Measures: Vaccination against influenza and pneumococcus.
C. Medical Treatment: - ABVD Regimen (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine)
D. Surgical Treatment: Excisional biopsy for diagnosis.
E. Interventional Procedures: Radiation therapy for localized disease.
F. Rehabilitation: Physical therapy for post-treatment fatigue.
G. Emergency Management: Radiation/steroids for SVC syndrome.
Highly favorable; 5-year survival rates exceed 85–90% with modern multi-modal therapy.
No primary prevention exists; focus is on early detection.
The following homeopathic remedies have been historically indicated for symptoms associated with Hodgkin Lymphoma. Selection should be based on individualized symptom totality and constitutional assessment.
This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Hodgkin Lymphoma.
Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, identify reference range variances, and generate a plain-English explanation of your disease risks.
Browse our full library of 200+ medical and pathology calculators.
📊 Browse All CalculatorsSpeak with our specialists for a customized treatment protocol for this condition.
📅 Request ConsultationThis clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.